Analyzing Adverse Events with JMP® Clinical
Join JMP Clinical expert Richard Zink, PhD, to learn more about the AE Incidence Screen in JMP Clinical software, which includes capabilities for multiplicity-adjustment to reduce the risk of false-positive findings and for graphically illustrating how adverse event risk changes over time.
You’ll come away with a better understanding of how JMP Clinical shortens the drug development process by streamlining safety reviews during clinical trials. Its unique combination of SAS® Analytics and dynamic JMP graphics provides a detailed picture of clinical trial results and eases communication between different groups of users.
Medical reviewers, epidemiologists, data monitors and biostatisticians use JMP Clinical for easy migration to CDISC, the worldwide standard for clinical reporting and analysis favored by the US Food and Drug Administration.